Novel peptide capable of specifically acting on biological membrane
OwnerSachiko Machida, Ken Tokuyasu +4inventors
InventorsSachiko Machida, Ken Tokuyasu, Shigeru Matsunaga, Yoshikiyo Sakakibara, Masuko Kobori, Zhesheng Wen
Life of this patent
Estimating the term…
Abstract
A peptide is provided, consisting of amino acid sequence comprising an amino acid sequence Z1X1X2X3Z2X4X5Z3X6X7X8Z4X9. where X1-X9 are any amino acids and at least two amino acids of Z1-Z4 are basic amino acids. An analog thereof is also provided.
Claims96
A peptide consisting of amino acid sequence comprising an amino acid sequence Z1X1X2X3Z2X4X5Z3X6X7X8Z4X9, wherein X1-X9 are any amino acids and at least two amino acids of Z1-Z4 are basic amino acids, or an analog thereof.
A peptide capable of specifically acting on a membrane of a microorganism, comprising a sequence selected from the group consisting of ALR, WALR, WGALR, RLAWG, GWALR, RVL, KVL, RVG, KVG, GVR, VGR, RVA, RSV, RVS, KVS, SVK, and VSK, or an anolog thereof.
A peptide capable of specifically acting on a membrane of an animal cell having an abnormality, comprising a sequence selected from the group consisting of ALR, WALR, WGALR, RLAWG, GWALR, RVL, KVL, RVG, KVG, GVR, VGR, RVA, RSV, RVS, KVS, SVK, and VSK, or an analog thereof.
A peptide, comprising:
- i) a first sequence selected from the group consisting of ALR, WALR, WGALR, RLAWG, GWALR, RVL, KVL, RVG, KVG, GVR, VGR, RVA, RSV, RVS, KVS, SVK, and VSK;
- ii) a second sequence selected from the group consisting of ALR, WALR, WGALR, RLAWG, GWALR, RVL, KVL, RVG, KVG, GVR, VGR, RVA, RSV, RVS, KVS, SVK, and VSK;
- and
- iii) a third sequence selected from the group consisting of ALR, WALR, WGALR, RLAWG, GWALR, RVL, KVL, RVG, KVG, GVR, VGR, RVA, RSV, RVS, KVS, SVK, and VSK.
A peptide, comprising a repeat of at least three sequences of KVL or ALR.
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122, or an analog thereof.
A peptide capable of specifically acting on a membrane of a microorganism, comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122, or an analog thereof.
A peptide capable of specifically acting on a membrane of an animal cell having an abnormality, comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122, or an analog thereof.
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122 or a variant thereof, wherein the variant has at least one amino acid deletion, addition, and/or substitution in the amino acid sequence, and maintains a property of specifically acting on a membrane of a microorganism.
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122 or a variant thereof, wherein the variant has at least one amino acid deletion, addition, and/or substitution in the amino acid sequence, and maintains a property of specifically acting on a membrane of an animal cell having an abnormality.
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122 or a variant thereof, wherein the variant has at least one conservative amino acid substitution in the amino acid sequence, and maintains a property of specifically acting on a membrane of a microorganism.
A peptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 11 to SEQ ID NO:
- 122 or a variant thereof, wherein the variant has at least one conservative amino acid substitution in the amino acid sequence, and maintains a property of specifically acting on a membrane of an animal cell having an abnormality.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or an analog thereof, wherein the peptide or the analog thereof has an ability to act on a membrane of a microorganism at least two fold higher than a peptide comprising a sequence KNWRGIAGMAKKLLGKNWKLM.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or an analog thereof, wherein the peptide or the analog thereof has an ability to act on a membrane of an animal cell having an abnormality at least two fold higher than a peptide comprising a sequence KNWRGIAGMAKKLLGKNWKLM.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or a variant thereof, wherein the variant has at least one amino acid deletion, addition, and/or substitution in the sequence-, maintains a property of specifically acting on a membrane of a microorganism, and has an ability to act on a membrane of a microorganism at least two fold higher than a peptide having a sequence KNWRGIAGMAKKLLGKNWKLM.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or a variant thereof, wherein the variant has at least one amino acid deletion, addition, and/or substitution in the sequence, maintains a property of specifically acting on a membrane of an animal cell having an abnormality, and has an ability to act on a membrane of an animal cell having an abnormality at least two fold higher than a peptide having a sequence KNWRGIAGMAKKLLGKNWKLM.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or a variant thereof, wherein the variant has at least one conservative amino acid substitution excluding K or R in the sequence, maintains a property of specifically acting a membrane of a microorganism, and has an ability to act on a membrane of a microorganism at least two fold higher than a peptide having a sequence KNWRGIAGMAKKLLGKNWKLM.
A peptide comprising a sequence RNWRGIAGMARRLLGRNWRLM or a variant thereof, wherein the variant has at least one conservative substitution excluding K or R in the sequence, maintains a property of specifically acting on a membrane of an animal cell having an abnormality, and has an ability to act on an ability to act on a membrane of an animal cell having an abnormality at least two fold higher than a peptide having a sequence KNWRGIAGMAKKLLGKNWKLM.
A library, comprising a plurality of nucleic acid sequences, each nucleic acid sequence comprising:
- (1) a first cassette comprising a base sequence encoding a first peptide;
- (2) a second cassette comprising a base sequence encoding a second peptide, said base sequence having the same reading frame as that of the base sequence encoding the first peptide, wherein the second peptide comprises a site allowing flexible movement of the first peptide:
- and
- (3) a third cassette comprising a base sequence essentially required for transcription and translation of the first and the second cassette, the third cassette being operatively linked to the first and second cassettes,
- wherein the number of the nucleic acid sequences in the library whose first cassettes are different from one another is at least two.
A method for screening for a nucleic acid encoding a peptide capable of acting on a biological membrane, the method comprising the steps of.:
- constructing a DNA library;
- preparing peptides by transcription and translation of DNAs of the library in a cell-free system, and forming complexes of the peptide, a ribosome, and mRNA;
- and
- selecting the complex capable of specifically binding to a membrane model.
A kit for screening for a nucleic acid encoding a peptide capable of acting on a biological membrane, the kit comprising:
- a lipid for preparing a membrane model.
A pharmaceutical composition for killing a microorganism, comprising a peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 5, 107, 121, and 122, or an analog or variant thereof.
A pharmaceutical composition for preventing putrefaction food or industrial products, comprising a peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 5, 107, 121, and 122, or an analog or variant thereof.
A pharmaceutical composition for treating an infectious disease caused by a microorganism, comprising a peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 5, 107, 121, and 122, or an analog or variant thereof.
A pharmaceutical composition for treating a cancer, comprising a peptide having an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 5, 107, 121, and 122, or an analog or variant thereof.
Dependencies are inferred from the claim text.